
201 - 500 employees
🧬 Biotechnology
🏥 Healthcare
💊 Pharmaceuticals
Biotechnology • Healthcare • Pharmaceuticals
ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (ADCs). The company focuses on transforming the lives of those impacted by cancer through a robust ADC portfolio targeting hematology and solid tumors. Their capabilities include a validated technology platform and a growing research & development toolbox, resulting in an approved product, ZYNLONTA®, for treating diffuse large B-cell lymphoma. Founded in 2011 and based in Lausanne, Switzerland, with operations in London and New Jersey, ADC Therapeutics is committed to confronting cancer and advancing treatment paradigms.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 6 days ago
Strategic accounts leader managing hematology sales teams across New York and New Jersey. Driving ZYNLONTA adoption among academic and healthcare stakeholders for ADC Therapeutics.
🕒 6 days ago
Associate Director leading New England hematology account strategy and an HTS team for ADC Therapeutics. Driving ZYNLONTA adoption across academic institutions through stakeholder engagement and compliant field execution.
🕒 October 9
Associate Director leading regional marketing for ADC Therapeutics’ cancer treatment ZYNLONTA across 13 U.S. states. Engaging hematology/oncology thought leaders, executing campaigns, and supporting conferences and advocacy events.
🕒 October 6
Medical Science Liaison advancing ADC Therapeutics’ antibody-drug conjugate therapies across the Southwest. Supporting hematology/oncology products, healthcare professionals, KOL relationships, and field medical insights.
🕒 September 11
Regional marketing leader advancing ADC Therapeutics’ antibody-drug conjugate cancer treatments across Western U.S. markets. Engaging hematology/oncology thought leaders, executing campaigns, and supporting ZYNLONTA commercialization.
🕒 September 11
Regional marketer advancing ADC Therapeutics’ antibody-drug conjugate cancer therapies across Mid-Atlantic hematology markets. Engaging thought leaders, executing campaigns, and supporting ZYNLONTA commercialization.
🕒 August 21
Senior clinical physician advancing ADC Therapeutics’ ZYNLONTA antibody-drug conjugate cancer program. Providing medical monitoring, safety oversight, and regulatory inspection readiness remotely.
🕒 July 24
Medical Science Liaison at ADC Therapeutics providing credible scientific info to healthcare professionals. Responsible for developing key relationships and maintaining medical expertise in oncology.